federal_register: E8-5217
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| E8-5217 | Implantation or Injectable Dosage Form New Animal Drugs; Penicillin G Procaine Aqueous Suspension | Rule | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by IVX Animal Health, Inc. The supplemental NADA provides for changing scientific nomenclature for a swine pathogen on labeling for penicillin G procaine aqueous suspension. | 2008-03-17 | 2008 | 3 | https://www.federalregister.gov/documents/2008/03/17/E8-5217/implantation-or-injectable-dosage-form-new-animal-drugs-penicillin-g-procaine-aqueous-suspension | https://www.govinfo.gov/content/pkg/FR-2008-03-17/pdf/E8-5217.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by IVX Animal Health, Inc. The supplemental NADA provides for changing scientific nomenclature... |